Oncologist explains new treatment for advanced melanoma called tumor-infiltrating lymphocyte therapy
Source: Medical Xpress, September 2024
Melanoma is a dangerous form of skin cancer that has the potential to spread to other parts of the body.
Approximately 100,000 people in the U.S. will be diagnosed with melanoma this year, according to the American Cancer Society. In early 2024, the Food and Drug Administration approved a new treatment for advanced melanoma called tumor-infiltrating lymphocyte therapy (TIL therapy).
Dr. James Jakub, a Mayo Clinic surgical oncologist, explains that TIL therapy can be a one-time treatment for some patients diagnosed with advanced melanoma.
